Lenalidomide as a novel treatment of acute myeloid leukemia.
about
Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.Efficacy and safety of lenalidomide for the treatment of acute myeloid leukemia: a systematic review and meta-analysisIMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML
P2860
Lenalidomide as a novel treatment of acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lenalidomide as a novel treatment of acute myeloid leukemia.
@en
type
label
Lenalidomide as a novel treatment of acute myeloid leukemia.
@en
prefLabel
Lenalidomide as a novel treatment of acute myeloid leukemia.
@en
P2860
P1476
Lenalidomide as a novel treatment of acute myeloid leukemia.
@en
P2093
Yiming Chen
P2860
P304
P356
10.1517/13543784.2013.758712
P407
P577
2013-01-15T00:00:00Z